Join
Live feed
·
PRReleasevia Quantisnow
Adaptimmune Therapeutics plc logo

Adaptimmune to Report Q3 2022 Financial and Business Updates on Tuesday, November 8, 2022

ByQuantisnow·Wall Street's wire, on your screen.
ADAP· Adaptimmune Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAP (Adaptimmune Therapeutics plc) and more on Quantisnow.